In this study, the authors demonstrated that restoring tryptophan with IDO1 inhibitors in a TRP-deprived milieu protected melanoma cells from being eliminated by T cells by recovering general protein synthesis triggered by IFNγ-induced tryptophan deprivation. Here, IDO1 is linked to melanoma.